Wang, T., Feng, Z., Jin, X., Fan, X., Crommen, J., Jiang, Y., Liposome electrokineticchromatography based in vitro model for early screening of the drug-inducedphospholipidosis risk (2014) J. Pharm. Biomed. Anal, 96, pp. 263-271
Balogh, G.T., Müller, J., Könczöl, á., pH-gradient PAMPA-based in vitro modelassay for drug-induced phospholipidosis in early stage of drug discovery (2013) Eur. J.Pharm. Sci, 49, pp. 81-89
Ploemen, J.P., Kender, J., Hafmans, T., Van de Sandt, H., Van Burgsteden, J.A., Saleminki, P.J., van Esch, E., Use of physicochemical calculation of pKaand C log Pto predict phospholipidosis-inducing potential: a case study with structurallyrelated piperazines (2004) Exp. Toxicol. Pathol, 55, pp. 347-355
Tomizawa, K., Sugano, K., Yamada, H., Horii, I., Physicochemical and cell-basedapproach for early screening of phospholipidosis-inducing potential (2006) J. Toxicol.Sci, 31, pp. 315-324
Zhou, L., Geraci, G., Hess, S., Yang, L., Wang, J., Argikar, U., Predicting phospho-lipidosis: a fluorescence noncell based in vitro assay for the determination ofdrug-phospholipid complex formation in early drug discovery (2011) Anal. Chem, 83, pp. 6980-6987
Jiang, Z., Reilly, J., Chromatography approaches for early screening of thephospholipidosis-inducing potential of pharmaceuticals (2012) J. Pharm. Biomed. Anal, 61, pp. 184-190
Wang, T., Feng, Y., Jin, X., Fan, X., Crommen, J., Jiang, Z., Liposome elec-trokinetic chromatography based in vitro model for early screening ofthe drug-induced phospholipidosis risk (2014) J. Pharm. Biomed. Anal, 96, pp. 263-271
